ScinoPharm Taiwan Ltd

Common Name
ScinoPharm Taiwan
Country
Taiwan
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
1789
Exchange
TAIWAN STOCK EXCHANGE
Description
Scinopharm Taiwan Ltd. operates as a specialized pharmaceutical company that focuses on the research, development, and manufacture of active pharmaceutical ingredients (APIs). Known for its strong emp...

ScinoPharm Taiwan Waste Data Preview

In 2023, ScinoPharm Taiwan conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into ScinoPharm Taiwan's Waste Treatment Practices

In 2023, ScinoPharm Taiwan generated a total of 4,073 metric tonnes of waste.

Of this amount, 26.39% of ScinoPharm Taiwan's total waste generated was recovered through methods such as recycling, reuse, or composting, while 73.61% was disposed of through landfilling, incineration, or combustion.

ScinoPharm Taiwan's Waste Recovery Rate

26%

How much of ScinoPharm Taiwan's waste is recycled or recovered?

In 2023, ScinoPharm Taiwan reported a total waste generation of 4,073 metric tonnes, of which 26.39% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that ScinoPharm Taiwan is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.

Has ScinoPharm Taiwan reduced its environmental waste footprint over time?

Since 2023, ScinoPharm Taiwan's total waste generation has increased by 43.7%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.

Over the same period, ScinoPharm Taiwan's waste recovery rate increased by 10.98%.

ScinoPharm Taiwan’s Waste Recovery vs. Disposal Over Time

2022202301.5 k3 k4.5 k6 ktonnes
  • Total Waste Disposed
  • Total Waste Recovered

Insights into ScinoPharm Taiwan’s Generation of Hazardous and Non-Hazardous Waste

In 2023, ScinoPharm Taiwan generated a total of 4,073 metric tonnes of waste.

Of this amount, 89.56% of ScinoPharm Taiwan's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 10.44% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

ScinoPharm Taiwan’s Hazardous vs Non-Hazardous Waste Over Time

2022202301.5 k3 k4.5 k6 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How ScinoPharm Taiwan reduced the environmental impact of its waste?

Since 2023, ScinoPharm Taiwan's total waste generation has increased by 43.7%, which may reflect expanding operations, weaker material efficiency, or insufficient waste reduction efforts.

Since 2023, ScinoPharm Taiwan's hazardous waste generation has increased by 0.77%, indicating a potential rise in the use of harmful materials, process inefficiencies, or limited hazardous waste reduction strategies..

Overall, ScinoPharm Taiwan's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.

How does ScinoPharm Taiwan treat its hazardous waste?

In 2023, ScinoPharm Taiwan reported that 3,648 metric tonnes of its total waste output were classified as hazardous. This represents 89.56% of its overall waste generation.

The company treated this hazardous waste using a combination of methods. Approximately 29.2% was managed through recovery methods, indicating a moderate integration of circular practices into its hazardous waste management. However, a significant share was still directed toward disposal, highlighting room for improvement in reducing the long-term impact of hazardous materials.

Breakdown of ScinoPharm Taiwan's Hazardous and Non-Hazardous Waste by Treatment Method

Hazardous WasteDisposed(63.4%)Hazardous WasteRecovered(26.2%)Non-Hazardous WasteDisposed(10.2%)
Want Full Access to ScinoPharm Taiwan's Waste Management Dataset?
Sign Up